vandetanib &#160; Turanci (Q7914515)

https://drugs.ncats.io/drug/YO460OQ37K

http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022405s010lbl.pdf

significant drug interaction ^Turanci

amiodarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

toremifene ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

anagrelide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

moxifloxacin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dronedarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

crizotinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

zuclopenthixol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pasireotide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ondansetron ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-hydroxyzine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

voriconazole ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

haloperidol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clarithromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

domperidone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

voriconazole ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

haloperidol ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-citalopram ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fosphenytoin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

epidermal growth factor receptor ^Turanci

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

harshen aiki ko suna

Turanci

retrieved ^Turanci

17 Agusta 2016

kinase insert domain receptor ^Turanci

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

harshen aiki ko suna

Turanci

retrieved ^Turanci

17 Agusta 2016

ret proto-oncogene ^Turanci

subject has role ^Turanci

enzyme inhibitor ^Turanci

1 reference

stated in ^Turanci

harshen aiki ko suna

Turanci

retrieved ^Turanci

17 Agusta 2016

legal status (medicine) ^Turanci

boxed warning ^Turanci

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)

pregnancy category ^Turanci

Australian pregnancy category D ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category D ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

LiverTox likelihood score ^Turanci

LiverTox toxicity likelihood category E* ^Turanci

1 reference

stated in ^Turanci

LiverTox ^Turanci

retrieved ^Turanci

8 Afirilu 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Vandetanib

last update ^Turanci

28 Yuni 2018

subject has role ^Turanci

protein kinase inhibitors ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

N0000182736

retrieved ^Turanci

5 Maris 2018

Commons category ^Turanci

Vandetanib

0 references

Identifiers

InChI ^Turanci

InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

Vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

Vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

443913-73-3

2 references

stated in ^Turanci

UNII ^Turanci

vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

9 Afirilu 2021

https://commonchemistry.cas.org/detail?cas_rn=443913-73-3

ChemSpider ID ^Turanci

2338979

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

Vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

PubChem CID ^Turanci

3081361

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

Vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

Reaxys registry number ^Turanci

9161676

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

vandetanib (Turanci)

retrieved ^Turanci

19 Oktoba 2016

ChEBI ID ^Turanci

49960

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

VANDETANIB (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)

International Chemical Identifier ^Turanci

InChI ^Turanci

ChEMBL ID ^Turanci

CHEMBL24828

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

VANDETANIB (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

SureChEMBL ID ^Turanci

SCHEMBL9044

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

splash10-000i-0293000000-9037b32a179af5e7ba9a

UniChem compound ID ^Turanci

263028

1 reference

stated in ^Turanci

UniChem ^Turanci

SPLASH ^Turanci

0 references

HSDB ID ^Turanci

8198

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

8198

ranar wallafa

28 Oktoba 2019

Vandetanib (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID1046681

2 references

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

InChIKey ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID9026681

0 references

LiverTox ID ^Turanci

Vandetanib

0 references

NSC number ^Turanci

744325

0 references

760766

0 references

EC number ^Turanci

669-841-4

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.195.611

retrieved ^Turanci

27 Disamba 2018

N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine (Turanci)

quotation ^Turanci

CAS no.: 443913-73-3 (Turanci)

ECHA Substance Infocard ID ^Turanci

100.195.611

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.195.611

retrieved ^Turanci

27 Disamba 2018

N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine (Turanci)

quotation ^Turanci

CAS no.: 443913-73-3 (Turanci)

Lambar ATC

L01XE12

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Vandetanib (Turanci)

17 Nuwamba 2015

1 reference

stated in ^Turanci

vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

MeSH descriptor ID ^Turanci

C452423

subject named as ^Turanci

N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine

0 references

RxNorm ID ^Turanci

1098413

1 reference

stated in ^Turanci

UNII ^Turanci

vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

DrugBank ID ^Turanci

DB05294

1 reference

InChIKey ^Turanci

UNII ^Turanci

YO460OQ37K

2 references

stated in ^Turanci

UNII ^Turanci

vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

MedlinePlus drug identifier ^Turanci

a612007

0 references

NDF-RT ID ^Turanci

N0000182736

1 reference

stated in ^Turanci

UNII ^Turanci

vandetanib (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

Probes And Drugs ID ^Turanci

PD003329

0 references

DrugCentral ID ^Turanci

4178

1 reference

stated in ^Turanci

UniChem ^Turanci

KEGG ID ^Turanci

D06407

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

vandetanib (Turanci)

retrieved ^Turanci

19 Oktoba 2016

PDB ligand ID ^Turanci

ZD6

0 references

Freebase ID ^Turanci

/m/026m12g

0 references

Microsoft Academic ID ^Turanci

2780333294

0 references

OpenAlex ID ^Turanci

C2780333294

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

PDB structure ID ^Turanci

2IVU

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

2IVU (Turanci)

retrieved ^Turanci

19 Oktoba 2016

UK Parliament thesaurus ID ^Turanci

434250

subject named as ^Turanci

Vandetanib

0 references

UMLS CUI ^Turanci

C1628324

1 reference

stated in ^Turanci